Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia
Completed · Phase 2
Conditions studied: Lactic Acidosis
In brief
OBJECTIVES: I. Determine the pharmacokinetics of sodium dichloroacetate (DCA) in patients with congenital lactic acidemia. II. Determine the efficacy of DCA in decreasing the frequency and/or severity of acute episodes of acidotic illness, improving linear growth, improving neurological or developmental function, or slowing neurological or developmental deterioration in these patients.
Key facts
- Study ID
- NCT00004493
- Run by
- University of California, San Diego
- People needed
- 75
- Starts
- 1998-09-01
- Expected to finish
- 2003-09-01
- Last updated by the study team
- 2015-03-25
Who can join
Age: 0 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego School of Medicine — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.